隆尼达胺通过减少SREBP1和抑制MAPK通路来改善MASH
Yuhan Chen1, Feiyan Pan2, Lusheng Tang3
1Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou 310014, China.
Acta biochimica et biophysica Sinica
|March 6, 2026
概括
隆尼达胺 (LND) 显示了对代谢功能障碍相关的脂肪肝炎 (MASH) 的治疗潜力. 它通过抑制MAPK通路并与SREBP1.1相互作用来减少炎症并改善脂质代谢.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
- 药理学 药理学是指药理学的学科.
背景情况:
- 代谢功能障碍相关的脂肪肝炎 (MASH) 是一个日益严重的全球健康问题,需要新的治疗干预措施.
- 隆尼达胺 (LND) 具有抗炎性质,但其在治疗MASH中的疗效在很大程度上仍未被探索.
研究的目的:
- 在MASH.的小鼠模型中研究隆尼达胺 (LND) 对炎症反应和脂质代谢的治疗作用.
- 阐明LND在MASH中的作用的基础分子机制.
主要方法:
- 一个MASH小鼠模型被诱导使用高脂肪,高胆固醇饮食.
- 实验室细胞模型被用来模拟炎症和脂质代谢.
- 用分子对接和生物层干扰计 (BLI) 来评估LND-SREBP1相互作用.
- 在AML12细胞中进行了SREBP1的特定淘汰.
主要成果:
- 治疗LND减轻了MASH相关的体重,血清葡萄糖和脂肪水平的增加.
- 在MASH小鼠中,LND显著降低了肝硬化和炎症反应.
- LND抑制了MAPK信号通路,并促进了SREBP1的降解.
- 证实了LND和SREBP1之间的直接相互作用,改善了脂质代谢.
结论:
- 隆尼达胺 (LND) 通过抑制MAPK通路来减少炎症,证明了MASH的显著治疗潜力.
- 通过直接相互作用和促进SREBP1降解,LND改善了异常的脂质代谢.
- LND 是MASH治疗的有前途的候选药物,需要进一步的临床研究.
相关概念视频
Adrenergic Agonists: Indirect-Acting Agents
2.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.9K
Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.7K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.7K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
1.1K
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.1K
Regulation of Nuclear Protein Sorting
3.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.4K

